CDC once again updates guidelines on testing people without COVID symptoms
New guideline says anyone who has been in contact with an infected person should be tested for Coronavirus
The US Centres for Disease Control and Prevention (CDC) has updated its guidelines for testing people who do not show symptoms of the novel Coronavirus. "Due to the significance of asymptomatic and pre-symptomatic transmission, this guidance further reinforces the need to test asymptomatic persons, including close contacts of a person with documented SARS-CoV-2 infection," the CDC said on its website on Friday.
"Testing is recommended for all close contacts of persons with SARS-CoV-2 infection. Because of the potential for asymptomatic and pre-symptomatic transmission, it is important that contacts of individuals with SARS-CoV-2 infection be quickly identified and tested," it added. It is a change from the CDC guidance released last month, which said testing might not be necessary for people without symptoms.
"Viral tests are recommended to diagnose acute infection of both symptomatic and asymptomatic individuals, to guide contact tracing, treatment options, and isolation requirements," according to the CDC website. The guidance notes that even if people do not have symptoms, they still need a test if they have been in close contact—such as within 6 feet—of a person with Coronavirus infection for at least 15 minutes.
"In areas where there are a small number of new cases and limited spread, your public health department may request a small number of asymptomatic 'healthy people' to be tested," said the updated guidance. If there is significant spread of the virus in the community, public health department may request significant numbers of asymptomatic "healthy people" to be tested in order to help stop the spread of the virus, according to the guidance. On August 24, the CDC changed COVID-19 testing guidelines on its website, no longer recommending testing for most people without symptoms.
Emergency tents, restrictions back in Madrid
Many residentsin Madrid will need a reason to leave their neighbourhoods as authorities try to rein in Europe's second Coronavirus wave. The Spanish capital's rate of transmission is more than double the national average, which already leads European contagion charts.
Russia approves R-Pharm's drug
Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.
Keep scrolling to read more news
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Sign up for all the latest news, top galleries and trending videos from Mid-day.comSubscribe